Moderna reported better third-quarter results than expected Thursday morning, as the vaccine maker reported a surprise profit ...

Stephane Bancel is stepping down as chief commercial officer of Moderna Inc., according to a person familiar with the matter.

Vaccine maker Moderna's chief executive officer Stephane Bancel will vacate his role as the company's chief commercial ...

Moderna (NASDAQ: MRNA) Q3 2024 Earnings Call Nov 07, 2024, 8:00 a.m. ET Good day, and thank you for standing by. Welcome to ...

Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...

Sales of Moderna’s COVID-19 shot exceeded expectations, but the company’s launch of its new RSV vaccine has started slowly.

Dr. Loughlin will join the Executive Committee and report to Chief Executive Officer Stephane Bancel. Jacqueline Miller, M.D., has been promoted to Chief Medical Officer, and will lead Moderna’s ...

Shares in Moderna rallied on Thursday after third-quarter revenues at the US biotech, best known for its Covid-19 vaccine, ...

A source tells Bloomberg that Stephane Bancel will step down as the company’s Chief Commercial Officer, but retain the role of ...

Moderna (MRNA) stock gains as company posts better than expected Q3 results driven by its updated COVID-19 vaccine. Read more ...

Investing.com - Moderna (NASDAQ:MRNA) has reported a shallower-than-anticipated loss in the third quarter and announced ...

He’s taking over a commercial assignment that was held by Stephane Bancel, who will remain chief executive officer. The moves ...